Saral Venture Builders

A Trusted Business Partner For Your All Early Stage Startup Dream

Saral Venture Builders

A Trusted Business Partner For Your All Early Stage Startup Dream

Saral Venture Builders

A Trusted Business Partner For Your All Early Stage Startup Dream

What's hot

Eyebot Secures $20M Series A in a Breakthrough for Eye-Care Access

Eyebot Secures $20M Series A in a Breakthrough for Eye-Care Access

In today’s fast-paced world, access to affordable and reliable healthcare remains a global challenge. Eye care, in particular, is often overlooked despite being one of the most essential aspects of overall health. Millions worldwide struggle with vision problems that could be corrected with timely prescriptions, but a lack of accessibility and affordability prevents many from...
Read more
Bluevine

Bluevine: The Ultimate 2025 Guide to Smarter Business Loans and Banking

In today’s fast-changing business world, small and medium-sized enterprises (SMEs) need banking solutions that go beyond traditional options. That’s where Bluevine steps in, offering entrepreneurs smarter ways to manage money, access loans, and grow their businesses. As we step into 2025, Bluevine has positioned itself as one of the most innovative players in the fintech...
Read more
ServiceNow

ServiceNow 2025: The Ultimate Guide to Smarter IT Service Management

In today’s fast-paced digital era, businesses depend heavily on technology to deliver seamless services, enhance productivity, and improve customer experiences. Managing IT services, however, is not an easy task. From resolving incidents to automating workflows, companies need robust solutions that streamline processes and eliminate inefficiencies. This is where ServiceNow, one of the world’s leading IT...
Read more
PharmEasy valuation 2024, PharmEasy financial struggles, Janus Henderson PharmEasy, API Holdings losses, PharmEasy IPO plans, healthtech valuation drop, Thyrocare acquisition, Indian startup funding

PharmEasy’s Valuation Drops to $456 Million Amid Financial Challenges

Introduction to PharmEasy’s Valuation Decline PharmEasy, once valued at $5.6 billion, has seen its valuation drop drastically to $456 million. The decline, revealed by investor Janus Henderson, underscores the challenges faced by the Indian healthtech company. Key Insights from the Report Janus Henderson’s Valuation Update This represents a 92% drop from PharmEasy’s peak valuation of...
Read more

Sustainable Construction: Eco-Friendly Practices for a Greener Future

The construction sector has historically been one of the largest contributors to carbon emissions, resource depletion, and waste generation. But as we enter 2025, the narrative is changing. Sustainable construction is emerging as the new standard, with builders, architects, and urban planners prioritizing eco-friendly methods that balance economic growth with environmental responsibility. This shift is...
Read more

The Psychology of Cybercrime: How Hackers Exploit Human Behavior

When most people think of cybercrime, they imagine advanced hackers writing lines of code, breaking through firewalls, or launching powerful malware. While technology does play a role, the truth is far simpler—and more unsettling. The majority of successful cyberattacks don’t happen because of weak software but because of human weakness. Hackers have mastered the art...
Read more
Handshake

Handshake 2025: The Ultimate Guide to Student Careers, Internships, and Job Opportunities

Finding the right career path after college has always been a challenge. For students and recent graduates, breaking into the job market requires not just skills, but also access to opportunities. Traditional job boards often fail to connect students with employers who understand their potential. That’s where Handshake comes in. As one of the fastest-growing...
Read more
1 … 4 5 6 7 8 … 11

Must Read

Popular Posts